SEC Filings

Filing date	Form	Description	View
02/16/24	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001415889-24-004258.pdf 0001415889-24-004258.rtf 0001415889-24-004258.xls
04/29/16	FWP	FWP	View HTML 0001104659-16-115511.pdf 0001104659-16-115511.rtf 0001104659-16-115511.xls
10/28/16	FWP	FWP	View HTML 0001104659-16-152698.pdf 0001104659-16-152698.rtf 0001104659-16-152698.xls
10/26/15	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-15-008037.pdf 0001047469-15-008037.rtf 0001047469-15-008037.xls
04/27/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-012613.pdf 0001047469-16-012613.rtf 0001047469-16-012613.xls
04/29/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-012708.pdf 0001047469-16-012708.rtf 0001047469-16-012708.xls
10/26/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-016313.pdf 0001047469-16-016313.rtf 0001047469-16-016313.xls
10/26/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-016312.pdf 0001047469-16-016312.rtf 0001047469-16-016312.xls
10/31/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-016386.pdf 0001047469-16-016386.rtf 0001047469-16-016386.xls
10/31/16	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001047469-16-016388.pdf 0001047469-16-016388.rtf 0001047469-16-016388.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.